News about Biotechnology

FDA Grants Tentative Approval to Amneal Pharmaceuticals' Generic Version of QVAR Inhalation Aerosol

Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in patients aged five years and older. It is not indicated for the relief of acute bronchospasm.

Biotechnology | 31/10/2025 | By Darshana

Medinet Japan partners with India's Stempeutics for Stempeucel cell therapy to treat CLTI

Medinet Co., Ltd, a Tokyo-listed regenerative medicine and CDMO company, has signed an option licence agreement with India-based Stempeutics Research for the development and commercialisation of its Stempeucel therapy in Japan, targeting Chronic Limb Threatening Ischaemia (CLTI).

Biotechnology | 29/10/2025 | By Darshana

DPIIT and Thermo Fisher Scientific Sign MoU to Strengthen India's Biotech Startup Ecosystem

The partnership between DPIIT and Thermo Fisher Scientific to support 500+ biotech startups through advisory, mentorship and nationwide challenge.

Biotechnology | 04/10/2025 | By Dineshwori |  108

Alkem Launches Pertuzumab Biosimilar Pertuza in India for HER2-Positive Breast Cancer

Alkem Laboratories has introduced Pertuza, a biosimilar of pertuzumab, in India for the treatment of HER2-positive breast cancer. The drug is supplied as a 420 mg/14 mL injection and is developed and manufactured domestically.

Biotechnology | 23/09/2025 | By Darshana |  168

Abzena Enhances AbZelectPRO Cell Line Offering with New GS Knockout Platforms

Named AbZelectPRO-KO and AbZelectPRO-KO+, the new GS knockout platforms are available as a stand-alone CLD offering, or as a fully integrated GMP programme, with fully transparent pricing to IND with no royalty fees. This flexible offering will enable customers to select a CLD strategy that aligns with their project-specific goals, timeline and budget.

Biotechnology | 15/09/2025 | By Dineshwori |  105

Cellectar Biosciences Partners with ITM to Secure Actinium-225 Supply for Cancer Drug Development

Cellectar Biosciences, Inc., a late-stage clinical biopharmaceutical company focused on cancer drug discovery and development, has entered into a supply agreement with ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech firm, for Actinium-225 (Ac-225).

Biotechnology | 15/09/2025 | By Darshana |  100

RION Forms INTENT Biologics to Develop Clinical Exosome-Based Therapies

With the launch of INTENT Biologics, RION targets global impact in inflammation care; Suneet Varma named CEO to lead the charge.

Biotechnology | 11/09/2025 | By Dineshwori |  143

Polpharma Biologics Partners with MS Pharma to Commercialize Biosimilars in MENA Region

Polpharma Biologics S.A., a biotechnology company specializing in the development and manufacturing of biosimilars, has entered into licensing agreements with MS Pharma, a leading biosimilar producer and distributor in the Middle East and North Africa (MENA) region.

Biotechnology | 03/09/2025 | By Darshana |  135

Bio-Thera and Gedeon Richter Secure EC Approval for Usymro, a Stelara Biosimilar

Bio-Thera Solutions Inc., a commercial-stage biopharmaceutical company, announced that the European Commission (EC) has approved BAT2206 (ustekinumab), a biosimilar referencing Janssen’s Stelara, following a positive opinion from the EMA’s CHMP on June 19, 2025. The product will be marketed in Europe by Gedeon Richter under the brand name Usymro.

Biotechnology | 28/08/2025 | By Darshana |  142

India's Biotechnology Makes Rapid Strides Under BioE3 Policy, Poised for USD 300 Billion by 2030: Dr. Jitendra Singh

Marking One Year of BioE3 Policy, Dr. Jitendra Singh launched the BioE3 Challenge for Youth and the country’s first National Biofoundry Network, calling it a step towards making biotechnology a driver of India’s economy, environment and employment.

Biotechnology | 28/08/2025 | By Dineshwori |  156